Where Does AR Fit into the Next Generation of Video Calls?

On Spatial Perspectives, host Dan Cui will have a one-on-one dialog with innovators and thought leaders in the growing Spatial Reality, or Spatial Computing, market. Cui will invite guests who can discuss the real world use cases of the technology and how it could benefit mankind while exploring any drawbacks and how they might be mitigated.

 

The next generation of video calls is here, powered by AR. To discuss this new AR technology application, host Dan Cui welcomed Ryan Fink, Founder, and CEO of Streem. Streem offers a platform that takes video calls to the next level, facilitating better communication and collaboration with AR.

Fink explained the three pillars of the product. “First is the video, then AR enhances the experience, and finally is the data capture to extract context, spatial information, measurements, and images.”

Streem experienced a lot of interest once the pandemic hit. “It accelerated adoption, for sure, as businesses need to keep doors open and couldn’t physically go into spaces,” Fink noted.

That need led to collaborations with businesses big and small, including Lowe’s. “They jumped on the technology and offered it for free to their contractor network,” Fink shared.

Other companies use it with great results, including diagnosing repair issues remotely so that contractors come with the right parts and spend as little time as possible in the customer’s home.

Fink also spoke about a cleaning company using the program for quoting. “They can virtually see the space, capture video and data, and quote remotely. They are using Streem for 82% of their quotes. It also allowed them to allot the exact amount of time to clean the space,” he added.

What’s next for the app and the AR industry? Cui and Fink discussed the use of LIDAR, which allows for 3-D masking and interacting with models.

Listen to Previous Episodes of Spatial Perspectives Right Here!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More